Get the Stockscreener App
68.78
0.47%
-0.34
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $68.78, with a volume of 745.69K.
It is down -0.47% in the last 24 hours and down -4.20% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$69.12
Open:
$68.9
24h Volume:
745.69K
Relative Volume:
0.40
Market Cap:
$33.25B
Revenue:
$10.63B
Net Income/Loss:
$819.00M
P/E Ratio:
41.49
EPS:
1.6577
Net Cash Flow:
$1.59B
1W Performance:
-4.77%
1M Performance:
-4.20%
6M Performance:
-15.95%
1Y Performance:
-12.80%
1-Day Range:
$68.73
$69.37
1-Week Range:
$68.73
$73.22
52-Week Range:
$61.84
$87.64
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC vs ISRG, BDX, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
68.79 | 33.41B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
351.51 | 123.70B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.31 | 48.78B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
219.28 | 31.89B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.38 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-26 | Initiated | William Blair | Mkt Perform |
| Jan-20-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-09-26 | Downgrade | Stifel | Buy → Hold |
| Dec-11-25 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
RXST: U.S. growth, deeper LAL adoption, and Alcon partnership drive a disciplined transformation strategy - TradingView
Alcon stock eases but stays supported by recent H1 2026 growth - AD HOC NEWS
Alcon stock dips as investors weigh product news and upcoming Q3 2026 earnings - AD HOC NEWS
Alcon stock heads into the open after a modest September 7, 2026 decline - AD HOC NEWS
Alcon stock edges lower as investors weigh recent performance and upcoming Q3 earnings - AD HOC NEWS
Alcon Inc. (ALC) Stock Analysis: Exploring A Promising 20.91% Upside Potential - DirectorsTalk Interviews
Alcon stock heads into the open after a modest decline - AD HOC NEWS
Alcon Stock Price Forecast. Should You Buy ALC? - StockInvest.us
Alcon introduces UNITY M ophthalmic microscope - glance.eyesoneyecare.com
Alcon stock trades softer as options activity and Q2 growth shape investor view - AD HOC NEWS
Alcon Market Sentiment - es.benzinga.com
Alcon stock eases after UNITY M launch and strong Q2 figures - AD HOC NEWS
The Back-to-School Essential Parents Are Overlooking: Eye Exams - Scripps News
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Deliveri - GuruFocus
Alcon stock dips in Zurich as UNITY M launch follows strong Q2 2026 figures - AD HOC NEWS
Alcon Announces Initial Launch of UNITY M Surgical Microscope in US, Japan - marketscreener.com
Alcon Debuts UNITY M Ophthalmic Surgical Microscope in U.S., Japan - Medical Product Outsourcing
Alcon: A Re-Rating In Eyesight - Seeking Alpha
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control - Nasdaq
Are Options Traders Betting on a Big Move in Alcon Stock? - TradingView
Changes in working capital of Alcon AG – BX:2U3 - TradingView
Alcon stock holds near 52 week high after Q2 beat - AD HOC NEWS
Alcon (SWX:ALC), What Is Behind The Fresh Attention? - Yahoo Finance
Alcon's Clareon Monofocal IOL Receives EUMDR Certification Through TÜV SÜD - Yahoo Finance
Alcon stock holds steady as drug pricing deal and Q2 reset shape outlook - AD HOC NEWS
Alcon stock edges higher as Q2 2026 impairment and earnings reset the outlook - AD HOC NEWS
Alcon Inc. (ALC) Stock Analysis: A Closer Look At Its 18.37% Potential Upside - DirectorsTalk Interviews
Alcon stock holds steady as latest impairment reshapes its earnings picture - AD HOC NEWS
Precision Trading with Alcon Inc. (ALC) Risk Zones - news.stocktradersdaily.com
Alcon stock slips as revenue rises 8.0% in Q2 - AD HOC NEWS
Alcon prices €500M senior notes at 3.875%, due 2033 - app.dealroom.co
Alcon Rolls Out UNITY CS Platform in Canada - Medical Product Outsourcing
Alcon (ALC) Institutional Ownership 2026 $ALC - MarketBeat
Alcon prices €500 million senior notes due 2033 By Investing.com - Investing.com Canada
Alcon stock holds steady as Q2 2026 earnings and guidance frame valuation - AD HOC NEWS
Alcon prices €500 million senior notes due 2033 - Investing.com
SGA Exits Alcon (ALC) as Cataract Demand Slows and Competition Rises - AlphaStreet
Alcon stock edges lower as Swiss shares hover around CHF 58.62 after recent gains - AD HOC NEWS
Alcon’s Q2 2026 Growth Shows UNITY Momentum, but Cataract Softness and Implantables Competition Still Matter - AlphaStreet
Alcon Inc. (ALC): Investor Outlook On Its 15.77% Potential Upside - DirectorsTalk Interviews
Alcon stock trades steadily as analyst targets signal upside - AD HOC NEWS
Alcon stock steady after Q2 2026 sales rise 8 percent - AD HOC NEWS
Alcon stock holds after Q2 sales rose 8 percent - Ad-hoc-news.de
Alcon stock holds in mid-$70 range as Q2 2026 sales rise 8 percent - Ad-hoc-news.de
Alcon stock edges higher after Q2 2026 sales rise and steady mid-$70 trading level - Ad-hoc-news.de
Alcon stock holds steady as analysts point to upside from latest market cap and valuation context. - Ad-hoc-news.de
What Makes Alcon (ALC) a Bullish Bet? - Yahoo Finance
Resilient Alcon stock holds near $73 as Q2 2026 sales and profit outpace growth in eye-care segments - Ad-hoc-news.de
World Council of Optometry, Alcon, and IACLE Partner to Advance Dry Eye Education - InvisionMag.com
Alcon stock trades around $73 as Q2 2026 profit growth and dry eye push shape expectations - AD HOC NEWS
Alcon stock holds in the low $70s as Q2 2026 growth and dry eye push shape the outlook - AD HOC NEWS
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.26%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):